Skip to main content
Erschienen in: Journal of Clinical Immunology 4/2023

17.01.2023 | Original Article

A Novel Deletion in FERMT3 Causes LAD-III in a Turkish Family

verfasst von: Nezihe Köker, İhsan Deveci, Karin van Leeuwen, Sinan Akbayram, Dirk Roos, Taco W. Kuijpers, Mustafa Yavuz Köker

Erschienen in: Journal of Clinical Immunology | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Leukocyte adhesion deficiency-III (LAD-III) is an extremely rare autosomal recessive syndrome caused by mutations in FERMT3, the gene encoding kindlin-3. The genetic alterations in this gene lead to abnormal expression or activity of kindlin-3 in leukocytes and platelets. Kindlin-3 acts as an important regulator of integrin activation. LAD-III has features of the bleeding syndrome of Glanzmann and also of leukocyte adhesion deficiency. In this study, we report on two families, one of Turkish and one of Syrian origin, with clinical features of LAD-III, loss of kindlin-3 protein expression, and a functional leukocyte defect. A novel, homozygous deletion in FERMT3 (c.921delC, p.Ser307Argfs*21) was found in the Turkish patient. The parents were carriers of the mutation, consistent with an autosomal recessive inheritance. A common c.1525C > T (p.Arg509*) mutation was found in the Syrian patient. In conclusion, beside the variant c.1525C > T in the FERMT3 gene, which was previously found in more than 15 patients in Anatolia, our study is the first to identify the novel homozygous variant c.921delC in the FERMT3 gene.
Literatur
1.
Zurück zum Zitat Van De Vijver E, Maddalena A, Sanal Ö, Holland SM, Uzel G, Madkaikar M, et al. Hematologically important mutations: leukocyte adhesion deficiency (first update). Blood Cells Mol Dis. 2012;48(1):53–61.CrossRefPubMed Van De Vijver E, Maddalena A, Sanal Ö, Holland SM, Uzel G, Madkaikar M, et al. Hematologically important mutations: leukocyte adhesion deficiency (first update). Blood Cells Mol Dis. 2012;48(1):53–61.CrossRefPubMed
2.
Zurück zum Zitat Kuijpers TW, Bruggen RV, Kamerbeek N, Tool AT, Hicsonmez G, Gurgey A, et al. Natural history and early diagnosis of LAD-1/variant syndrome. Blood. 2007;109(8):3529–37.CrossRefPubMed Kuijpers TW, Bruggen RV, Kamerbeek N, Tool AT, Hicsonmez G, Gurgey A, et al. Natural history and early diagnosis of LAD-1/variant syndrome. Blood. 2007;109(8):3529–37.CrossRefPubMed
3.
Zurück zum Zitat Etzioni A, Alon R. Leukocyte adhesion deficiency III: a group of integrin activation defects in hematopoietic lineage cells. Curr Opin Allergy Clin Immunol. 2004;4(6):485–90.CrossRefPubMed Etzioni A, Alon R. Leukocyte adhesion deficiency III: a group of integrin activation defects in hematopoietic lineage cells. Curr Opin Allergy Clin Immunol. 2004;4(6):485–90.CrossRefPubMed
4.
Zurück zum Zitat Kuijpers TW, van de Vijver E, Weterman MA, de Boer M, Tool AT, van den Berg TK, et al. LAD-1/variant syndrome is caused by mutations in FERMT3. Blood. 2009;113(19):4740–6.CrossRefPubMed Kuijpers TW, van de Vijver E, Weterman MA, de Boer M, Tool AT, van den Berg TK, et al. LAD-1/variant syndrome is caused by mutations in FERMT3. Blood. 2009;113(19):4740–6.CrossRefPubMed
5.
Zurück zum Zitat Robert P, Canault M, Farnarier C, Nurden A, Grosdidier C, Barlogis V, et al. A novel leukocyte adhesion deficiency III variant: kindlin-3 deficiency results in integrin-and nonintegrin-related defects in different steps of leukocyte adhesion. J Immunol. 2011;186(9):5273–83.CrossRefPubMed Robert P, Canault M, Farnarier C, Nurden A, Grosdidier C, Barlogis V, et al. A novel leukocyte adhesion deficiency III variant: kindlin-3 deficiency results in integrin-and nonintegrin-related defects in different steps of leukocyte adhesion. J Immunol. 2011;186(9):5273–83.CrossRefPubMed
6.
Zurück zum Zitat Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678–89.CrossRefPubMed Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678–89.CrossRefPubMed
7.
Zurück zum Zitat Svensson L, Howarth K, McDowall A, Patzak I, Evans R, Ussar S, et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med. 2009;15(3):306–12.CrossRefPubMedPubMedCentral Svensson L, Howarth K, McDowall A, Patzak I, Evans R, Ussar S, et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med. 2009;15(3):306–12.CrossRefPubMedPubMedCentral
8.
9.
Zurück zum Zitat Köker MY, Sarper N, Albayrak C, Zulfikar B, Zengin E, Saraymen B, et al. New αiibβ3 variants in 28 Turkish glanzmann patients; structural hypothesis for complex activation by residues variations in i-egf domains. Platelets. 2022;33(4):551–61.CrossRefPubMed Köker MY, Sarper N, Albayrak C, Zulfikar B, Zengin E, Saraymen B, et al. New αiibβ3 variants in 28 Turkish glanzmann patients; structural hypothesis for complex activation by residues variations in i-egf domains. Platelets. 2022;33(4):551–61.CrossRefPubMed
10.
Zurück zum Zitat Van de Vijver E, Tool AT, Sanal Ö, Çetin M, Ünal S, Aytac S, et al. Kindlin-3–independent adhesion of neutrophils from patients with leukocyte adhesion deficiency type III. J allergy Clin Immunol. 2014;133(4):1215–8.CrossRefPubMed Van de Vijver E, Tool AT, Sanal Ö, Çetin M, Ünal S, Aytac S, et al. Kindlin-3–independent adhesion of neutrophils from patients with leukocyte adhesion deficiency type III. J allergy Clin Immunol. 2014;133(4):1215–8.CrossRefPubMed
11.
Zurück zum Zitat Mory A, Feigelson SW, Yarali N, Kilic SS, Bayhan GI, Gershoni-Baruch R, et al. Kindlin-3: a new gene involved in the pathogenesis of LAD-III. Blood. 2008;112(6):2591–2591.CrossRefPubMed Mory A, Feigelson SW, Yarali N, Kilic SS, Bayhan GI, Gershoni-Baruch R, et al. Kindlin-3: a new gene involved in the pathogenesis of LAD-III. Blood. 2008;112(6):2591–2591.CrossRefPubMed
12.
Zurück zum Zitat Manevich EM, Feigelson SW, Pasvolsky R, Aker M, Grabovsky V, Shulman Z, et al. Loss of kindlin-3 in LAD-III eliminates LFA-1 but not VLA-4 adhesiveness developed under shear flow conditions. Blood. 2009;114(11):2344–53.CrossRef Manevich EM, Feigelson SW, Pasvolsky R, Aker M, Grabovsky V, Shulman Z, et al. Loss of kindlin-3 in LAD-III eliminates LFA-1 but not VLA-4 adhesiveness developed under shear flow conditions. Blood. 2009;114(11):2344–53.CrossRef
13.
Zurück zum Zitat Aygun D, Nepesov S, Gershoni R, Camcıoglu Y. Leukocyte adhesion deficiency III: report of two siblings. Pediatr Neonatol. 2017;58(1):99–100.CrossRefPubMed Aygun D, Nepesov S, Gershoni R, Camcıoglu Y. Leukocyte adhesion deficiency III: report of two siblings. Pediatr Neonatol. 2017;58(1):99–100.CrossRefPubMed
14.
Zurück zum Zitat Suratannon N, Yeetong P, Srichomthong C, Amarinthnukrowh P, Chatchatee P, Sosothikul D, et al. Adaptive immune defects in a patient with leukocyte adhesion deficiency type III with a novel mutation in FERMT3. Pediatr Allergy Immunol. 2016;27(2):214–7.CrossRefPubMed Suratannon N, Yeetong P, Srichomthong C, Amarinthnukrowh P, Chatchatee P, Sosothikul D, et al. Adaptive immune defects in a patient with leukocyte adhesion deficiency type III with a novel mutation in FERMT3. Pediatr Allergy Immunol. 2016;27(2):214–7.CrossRefPubMed
Metadaten
Titel
A Novel Deletion in FERMT3 Causes LAD-III in a Turkish Family
verfasst von
Nezihe Köker
İhsan Deveci
Karin van Leeuwen
Sinan Akbayram
Dirk Roos
Taco W. Kuijpers
Mustafa Yavuz Köker
Publikationsdatum
17.01.2023
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 4/2023
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-022-01420-4

Weitere Artikel der Ausgabe 4/2023

Journal of Clinical Immunology 4/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.